Hjem › Interstitielle lungesygdomme › New Mexico
Interstitielle lungesygdomme kliniske forsøg i New Mexico
5 studier for Interstitielle lungesygdomme søger deltagere på steder i New Mexico.
Byer i New Mexico
Officiel studietekst (engelsk)
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of New Mexico, Albuquerque
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 29. sep. 2026 · NCT05798923Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- University of New Mexico, Albuquerque
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT06911632A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Albuquerque
RekruttererFase 2
Alder 18 til 85 · Alle køn · Opdateret 2. sep. 2026 · NCT07333183DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of New Mexico Health Sciences Center, Albuquerque
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 26. aug. 2026 · NCT06388421Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- University of New Mexico, Albuquerque
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 13. jul. 2026 · NCT05943535Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.